Results 101 to 110 of about 40,241 (253)
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Background and Objectives Preventive tuberculosis (TB) therapy before initiating MTX or IL‐17/IL‐23/IL‐12/23p40 inhibitors for latent tuberculosis infection (LTBI) is supported by indirect evidence of TB reactivations with TNF inhibitors. However, direct evidence for MTX or IL‐17/IL‐23/IL‐12/23p40 inhibitors is limited.
Christoph Zeyen +4 more
wiley +1 more source
Jefferson Digital Commons quarterly report: October-December 2016 [PDF]
, 2016 This quarterly report includes: New departments joining the JDC Statistics for 2016 Assorted assets added to the JDC in the last quarter What people are saying about the ...
Copeland, LIBT, James +2 more
core +2 more sources
Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes
Drugs, 2018 IntroductionTo evaluate the possibility that switching from reference biologic medicines to biosimilars could lead to altered clinical outcomes, including enhanced immunogenicity, compromised safety, or diminished efficacy for patients, a systematic ...
Hillel P. Cohen +5 more
semanticscholar +1 more source
Impact of adalimumab treatment on impairment of non‐professional activities in psoriasis patients
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Background and objectives Psoriasis can result in reduced quality of life, work productivity loss, and a significant restriction in non‐professional activities. This study investigates the effects of long‐term treatment with adalimumab regarding work ability, non‐professional activities, and health‐related quality of life in a large real‐word ...
Georgios Kokolakis +4 more
wiley +1 more source
Has The Era Of Slow Growth For Prescription Drug Spending Ended? [PDF]
, 2016 In the period 2005–13 the US prescription drug market grew at an average annual pace of only 1.8 percent in real terms on an invoice price basis (that is, in constant dollars and before manufacturers’ rebates and discounts). But the growth rate increased
Aitken, M. +4 more
core +1 more source
G-CSF and G-CSF biosimilars: a meta-analysis of randomized clinical trials in breast cancer patients [PDF]
, 2017 Edoardo Botteri +2 more
openalex +1 more source
Making Advanced Therapies Affordable and Accessible: Two Strategic Approaches
Developing World Bioethics, EarlyView.ABSTRACT This article explores two complementary strategies for addressing the affordability and access challenges facing advanced therapies. As high development costs and limited market access have led to the withdrawal of several therapies, the article examines how these barriers create ‘valleys of death’ that prevent innovation from reaching ...
Ubaka Ogbogu, Lauren Albrecht
wiley +1 more source
Pharmaceutical patenting trends on drugs and lifestyle diseases: an analysis of Indian and global status [PDF]
, 2017 The Indian pharmaceutical sector is large and has the potential of a global leader for low-priced high-quality drugs. The new patent regulations had a strong impact on the drug industry in India.
Chakraborty, Kajal +2 more
core +1 more source